-
IntroducedFeb 22, 2024
-
Passed Senate
-
Passed House
-
Signed into Law
Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases
Last Action See all actions
Senate • Apr 04, 2024: Amended, laid over for possible inclusion in the omnibus bill (Committee on Health and Human Services)
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on SF 4058
Tweets
Whip Lists
Sponsors
Votes
Actions
- Apr 04, 2024 | Senate
- Meeting scheduled for 08:30 AM in Room 1100 Minnesota Senate Bldg. (Committee on Health and Human Services)
- Amended, laid over for possible inclusion in the omnibus bill (Committee on Health and Human Services)
- Feb 22, 2024 | Senate
- Introduction and first reading
- Referred to Health and Human Services
- See HF5247
Bill Texts
Documents